Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Sarcoma 1Neuroma, Acoustic 1Neurofibromatosis 2 1Neurilemmoma 1Neoplasm Metastasis 1Multiple Myeloma 1Meningioma 1Leukemia, Myeloid, Acute 1Congenital Abnormalities 1Carcinoma, Renal Cell 1

Interventions

Radiosurgery 6Bevacizumab 4Gentamicins 3Everolimus 3Cochlear Implants 3Lapatinib 2tozuleristide 1neratinib 1icotinib 1gallium Ga 68 dotatate 1brigatinib 1Triamcinolone Acetonide 1Sufentanil 1Sirolimus 1Microsurgery 1Methylprednisolone 1Magnetic Resonance Spectroscopy 1Losartan 1Head Movements 1HDAC-42 1Fluoresceins 1Fluorescein 1Exome 1Endostatins 1Endoscopes 1Docosahexaenoic Acids 1Decision Support Techniques 1Axitinib 1Aspirin 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neuroma, Acoustic × HDAC-42 × Clear all
NCT02282917 2025-12-05

Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma

Massachusetts Eye and Ear Infirmary

Phase EARLY_PHASE1 Terminated
7 enrolled 19 charts
CNS

Meningioma, Neurilemmoma, Neuroma, Acoustic, Neurofibromatosis 2

Data powered by HemOnc (CC BY 4.0) Colophon âš¡